PARMAR KUSH Insider Trades

Insider Trading History

Track insider trading activity for PARMAR KUSH. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $138k 19,000 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 19,000 shares
$5.97
$7.24
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $21.5M 2,963,066 shares
Last Trade
Nov 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.76M 200,000 shares
$8.80
$7.24
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $22.9M 3,163,066 shares
Last Trade
Jul 09, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$203k 27,000 shares
$7.50
$7.24
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $23M 3,183,131 shares
Last Trade
Jul 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$178k 25,000 shares
$7.12
$7.24
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $23.2M 3,201,709 shares
Last Trade
Jun 30, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$170k 25,000 shares
$6.81
$7.24
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $23.3M 3,220,287 shares
Last Trade
Jun 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$518k 75,000 shares
$6.91
$7.24
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $138k 19,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 19,000 shares
$7.90
$7.24
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $116k 16,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$263k 16,000 shares
$16.45
$7.24
Rallybio
Rallybio RLYB
Director
Holding Value $259k 16,500 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.5k 16,500 shares
$1.91
$15.70
Rallybio
Rallybio RLYB
Director
Holding Value $426k 27,118 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65.1k 27,118 shares
$2.40
$15.70
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $116k 16,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$235k 16,000 shares
$14.67
$7.24
Rallybio
Rallybio RLYB
Director
Holding Value $243k 15,490 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.4k 15,490 shares
$5.64
$15.70
Rallybio
Rallybio RLYB
Director
Holding Value $37.3M 2,378,969 shares
Last Trade
Mar 07, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$820k 100,000 shares
$8.20
$15.70
Rallybio
Rallybio RLYB
Director
Holding Value $162k 10,344 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64k 10,344 shares
$6.19
$15.70
Akouos
Akouos AKUS
Director
Holding Value $0 0 shares
Last Trade
Dec 01, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$213k 16,000 shares
$13.29
$13.29
Akouos
Akouos AKUS
Director
Holding Value $0 0 shares
Last Trade
Nov 30, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$13.1M 982,453 shares
$13.29
$13.29
Akouos
Akouos AKUS
Director
Holding Value $213k 16,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.4k 16,000 shares
$4.21
$13.29
Homology Medicines
Homology Medicines FIXX
Director
Holding Value $16.8k 18,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.8k 18,000 shares
$1.88
$0.93
Vor Biopharma
Vor Biopharma VOR
Director
Holding Value $251k 16,911 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72k 16,911 shares
$4.26
$14.85
Rallybio
Rallybio RLYB
Director
Holding Value $38.9M 2,478,969 shares
Last Trade
Jun 03, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$923k 99,671 shares
$9.26
$15.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up